We serve Chemical Name:(4-chloro-2-fluoro-5-methoxyphenyl)boronic acid CAS:153122-60-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-chloro-2-fluoro-5-methoxyphenyl)boronic acid
CAS.NO:153122-60-2
Synonyms:2-fluoro-4-chloro-5-methoxyphenylboronic acid;4-chloro-2-fluoro-5-methoxybenzeneboronic acid;4-CHLORO-2-FLUORO-5-METHOXYPHENYLBORONIC ACID
Molecular Formula:C7H7BClFO3
Molecular Weight:204.39100
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:339.193ºC at 760 mmHg
Density:1.511 g/cm3
Index of Refraction:
PSA:49.69000
Exact Mass:204.01600
LogP:0.16750
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-fluoro-4-chloro-5-methoxyphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-CHLORO-2-FLUORO-5-METHOXYPHENYLBORONIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-2-fluoro-5-methoxybenzeneboronic acid Use and application,4-CHLORO-2-FLUORO-5-METHOXYPHENYLBORONIC ACID technical grade,usp/ep/jp grade.
Related News: Zynteglo, a gene therapy for the blood disorder beta thalassaemia, uses a viral vector (or modified virus) to deliver a working gene into the patient’s blood cells. (4-phenylphenyl)methanamine,hydrochloride manufacturers Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. givescone suppliers On top of getting compensated for the past infringements, Plexxikon says it will receive “additional royalty payments for future sales of Tafinlar in the United States through the life of the patents.” 1-(2-chlorophenyl)-2,2,2-trifluoroethanone vendor & factory In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April.,Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients.
